相关实验视频
Updated: Jul 15, 2025

12:33
Corticospinal Excitability Modulation During Action Observation
Published on: December 31, 2013
8.9K
动作观察和运动图像改善了帕金森病患者的运动图像能力 - 一项功能性MRI研究
Elisabetta Sarasso1, Andrea Gardoni2, Lucia Zenere2
1Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics and Maternal Child Health, University of Genoa, Genoa, Italy.
Parkinsonism & related disorders
|September 29, 2023
概括
动作观察和运动影像训练 (AOT-MI) 改善了帕金森病患者的运动影像技能和大脑功能.
科学领域:
- 神经科学是一个神经科学.
- 康复医学 康复医学 康复医学
- 运动障碍 运动障碍
背景情况:
- 帕金森病 (PD) 伴有姿势不稳定和步态障碍 (PD-PIGD) 可能会损害运动图像 (MI) 技能.
- 评估特定培训干预措施对心脏病发作和PD-PIGD相关脑部变化的影响对于开发有效疗法至关重要.
研究的目的:
- 评估动作观察和运动影像训练 (AOT-MI) 结合步行/平衡练习对PD-PIGD患者的MI能力和大脑功能变化的影响.
- 将AOT-MI和步行/平衡训练组的结合结果与仅接受步行/平衡练习的组进行比较.
主要方法:
- 25名PD-PIGD患者被随机分为两个组:双任务+AOT-MI和双任务.
- 两组都接受了为期6周的步行/平衡训练;双任务+AOT-MI组额外接受了AOT-MI.
- 在训练前和训练后使用动感和视觉图像问卷 (KVIQ) 和功能性MRI (fMRI) 评估了运动图像. 基线比较与23个健康对照进行.
主要成果:
- 两组都改善了动感图像分数,但只有双任务+AOT-MI组在视觉和总KVIQ分数上有所改善.
- 在基线时,与对照组相比,PD患者表现出降低的感觉运动,时和小脑fMRI活动.
- 训练后,双任务+AOT-MI组在前带膜,前和运动小脑区域的活性增加,以及认知小脑区域的招募减少. 双任务组显示不同模式的大脑活动的变化.
结论:
- 动作观察和运动影像训练 (AOT-MI) 有效地提高PD-PIGD患者的运动影像能力.
- AOT-MI促进了对运动图像和步态/平衡控制至关重要的大脑区域的功能可塑性.
- 这些发现表明AOT-MI是改善PD-PIGD运动功能的有希望的治疗策略.
相关概念视频
Parkinson's Disease: Treatment
292
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
292
Parkinson's Disease: Overview
590
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
590

